About
Custom Peptides
Areas of Focus
Categories
Non-PharmaceuticalSan Diego & Southern California
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
2
As Collaborator
2
Total Enrollment
116
By Phase
PHASE2: 1PHASE1: 3
By Status
ACTIVE_NOT_RECRUITING: 2UNKNOWN: 1COMPLETED: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT04634747Lead Sponsor
Phase 2 Study to Evaluate PVX-410 + Pembrolizumab + Chemotherapy for Metastatic, PD-L1+ Triple-Negative Breast Cancer
PHASE2Unknown
53 participants
Started: Apr 30, 2022 · Completed: Apr 1, 2025
NCT02886065Collaborator
A Study of PVX-410, a Cancer Vaccine, and Citarinostat +/- Lenalidomide for Smoldering MM
PHASE1Active, not recruiting
19 participants
Started: Mar 7, 2017 · Completed: Sep 15, 2026
NCT02826434Collaborator
Adjuvant PVX-410 Vaccine and Durvalumab in Stage II/III Triple Negative Breast Cancer
PHASE1Active, not recruiting
22 participants
Started: Aug 18, 2016 · Completed: Sep 30, 2027
NCT01718899Lead Sponsor
Phase 1/2a Study of Cancer Vaccine to Treat Smoldering Multiple Myeloma
PHASE1Completed
22 participants
Started: Nov 30, 2012 · Completed: Sep 30, 2016
Locations (1)
Headquarters
San Diego, CA, United States
Map
Loading map...